Here are 3 healthcare shares you can buy and hold for a decade

The healthcare sector certainly has been the place to invest in 2017. As of yesterday’s close, the S&P/ASX 200 Health Care (Index: ^AXHJ) (ASX: XHJ) was up a staggering 17.6% year-to-date.

Despite this strong start to the year, I still believe there are plenty of investment opportunities available in the sector. Especially for those that are willing to make buy and hold investments.

Here are three which I think could be in the buy zone:

The performance of the CSL Limited (ASX: CSL) share price is a big reason the health care index has gained so much this year. The biotherapeutics company’s shares have been on a tear this year, rising a massive 32%. Whilst it is by no means a bargain buy any more, I still believe it could be a great buy and hold investment. Thanks to its lucrative immunoglobulins business and its fledgling Seqirus influenza vaccine business, I believe the company is positioned to deliver strong earnings growth for at least the next decade.

The Nanosonics Ltd. (ASX: NAN) share price may have rallied strongly in the last month, but it is still down 3% year-to-date. This could make it an ideal time to snap up the shares of the infection control specialist. Demand for its environmentally friendly and wholly effective ultrasound probe disinfection system has been growing at an incredible rate. Pleasingly this demand looks set to continue to grow for some time following the release of new guidelines for high level disinfection of ultrasound probes internationally. Management believes its trophon technology is perfectly positioned to meet the requirements outlined in the new guidelines.

I think the current Ramsay Health Care Limited (ASX: RHC) share price is at a great level for a long-term investment. Whilst 30x trailing earnings may be expensive, considering its strong growth prospects I think it is more than justified. Demand for its healthcare services is almost certainly going to grow at a strong rate over the next decade due to ageing populations, increased chronic disease burden, and improvement in treatments and diagnosis. With such strong tailwinds, I think Ramsay would be a great investment.

Finally, here are three more quality shares which I think would make fantastic buy and hold investments today. I'm tipping each of them for big things in the future.

Top 3 ASX Blue Chips To Buy In 2017

For many, blue chip stocks means stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool's in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool's Top 3 Blue Chip Stocks for 2017."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

If you're expecting to see the likes of Commonwealth Bank, Telstra and Wesfarmers shares on this list, you'll be sorely disappointed. Not only are their dividends growing at a snail's pace, their profits are under pressure too due to the increasing competitive environment.

The contrast to these "new breed" blue chips couldn't be greater... especially the very real prospect of significant share price gains, something that's looking less likely from the usual blue chip suspects.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand - and how quickly the share prices of these companies moves - we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia owns shares of Nanosonics Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.